Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Asset disposition
Inv. presentation
Acq. announced
INTERMUNE INC (ITMN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2014 8-K Quarterly results
09/29/2014 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...
Docs: "Amended and Restated Certificate of Incorporation of InterMune, Inc",
"Amended and Restated Bylaws of InterMune, Inc",
"Third Supplemental Indenture, between InterMune, Inc., Roche Holdings, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee",
"Fourth Supplemental Indenture, between InterMune, Inc., Roche Holdings, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee",
"JOINT MEDIA RELEASE"
09/05/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice to Holders of 2015 Notes",
"INTERMUNE ANNOUNCES ANTICIPATED FUNDAMENTAL CHANGE FOR 5.00% CONVERTIBLE SENIOR NOTES DUE 2015",
"Notice to Holders of 2017 Notes"
08/25/2014 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among InterMune, Inc., Roche Holdings, Inc. and Klee Acquisition Corporation",
"Roche and InterMune Reach Definitive Merger Agreement · Roche to acquire InterMune for $ 74.00 per share · InterMune’s lead product pirfenidone for idiopathic pulmonary fibrosis to expand Roche’s respiratory product portfolio"
08/06/2014 8-K Quarterly results
Docs: "INTERMUNE REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS"
07/17/2014 8-K Other Events
07/02/2014 8-K Regulation FD Disclosure
07/02/2014 8-K Unregistered Sales of Equity Securities
06/24/2014 8-K Unregistered Sales of Equity Securities
06/04/2014 8-K Submission of Matters to a Vote of Security Holders
06/03/2014 8-K Investor presentation
Docs: "Company slide presentation dated June 2014"
05/27/2014 8-K Other Events
05/19/2014 8-K Regulation FD Disclosure
05/01/2014 8-K Quarterly results
Docs: "INTERMUNE REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS, CLINICAL DEVELOPMENT AND BUSINESS HIGHLIGHTS"
03/19/2014 8-K Asset disposition
03/14/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement by and among InterMune, Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC",
"Opinion of Latham & Watkins LLP"
03/12/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "INTERMUNE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK",
"Risk Factors"
02/25/2014 8-K Investor presentation
Docs: "Company presentation"
01/13/2014 8-K Investor presentation
Docs: "INTERMUNE REPORTS PRELIMINARY FOURTH QUARTER 2013 ESBRIET ® REVENUE AND RECENT BUSINESS HIGHLIGHTS",
"Company slide presentation dated January 13-16, 2014"
12/02/2013 8-K Form 8-K - Current report
11/06/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement by and among InterMune, Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC",
"Opinion of Latham & Watkins LLP"
10/30/2013 8-K Quarterly results
Docs: "INTERMUNE REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS"
04/24/2013 8-K Quarterly results
Docs: "INTERMUNE REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS"
03/21/2013 8-K Other Events
03/04/2013 8-K Other Events
02/19/2013 8-K Entry into a Material Definitive Agreement
01/22/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Underwriting Agreement by and among InterMune, Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC",
"Underwriting Agreement by and among InterMune, Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC",
"Second Supplemental Indenture, between InterMune, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee (including the form of 2.50% convertible senior note due 2017)",
"Opinion of Latham & Watkins LLP",
"Opinion of Latham & Watkins LLP"
01/14/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "INTERMUNE ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND CONVERTIBLE DEBT",
"Risk Factors"
01/07/2013 8-K Investor presentation
Docs: "Company slide presentation dated January 7-10, 2013"
01/03/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "INTERMUNE REPORTS PRELIMINARY FOURTH QUARTER 2012 ESBRIET ® REVENUE AND OTHER RECENT BUSINESS HIGHLIGHTS"
11/30/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/29/2012 8-K Other Events
10/02/2012 8-K Other Events
09/11/2012 8-K Other Events
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy